This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
| INTRODUC TI ON
Aortic dissection (AD), as one of the highly lethal vascular diseases, cannot be reliably prevented pharmacologically thus far because the molecular mechanism of AD is poorly understood and hence dissection, progression, and rupture. Therefore, it is pivotal to further explore the mechanisms of AD. 1 As the major cells in aortic media layer, VSMCs have been taken as playing a key role in maintaining homeostasis of the aortic wall. [2] [3] [4] Of note, dysfunction of proliferation and migration in VSMCs has been reported to be involved in the development of vascular diseases. 5, 6 MicroRNA is a class of evolutionarily conserved, noncoding small RNAs that negatively regulate the expression of protein-coding gene transcripts. Previous studies revealed the involvement ofmiR146a-5p in modulating immune system and in myeloid tumorigenesis. 7 Further, bioinformatics indicated that miR146a-5p participated in cell proliferation and migration. 8 Thus, considerable attention has been attracted to the role of miR146a-5p in vascular diseases. However, the causal relationship between miR146a-5p and AD has never been reported.
In this study, the upregulation of miR146a-5p in aortic specimens of AD was confirmed. It revealed the effects of miR146a-5p on VSMCs function. Further, in vitro data indicated that the expression of SMAD4, a member of TGF-β family, was regulated by mi-R146a-5p. Further, circulating miR-146a-5p is significantly higher in the AD group compared to the control group. Taken together, the results shed new light on the involvement of miRNAs in the molecular regulation of VSMC function and AD.
| MATERIAL S AND ME THODS

| Participants' recruitment and sample collection
Plasma samples were obtained from 43 patients with AD Stanford type A and 36 healthy controls, respectively. Whole venous blood (5-10 mL) was extracted from elbow vein after 12-to 14-hours fasting and then centrifuged at 3000 rpm for 10 minutes under room temperature. After phase separation, plasma was collected and stored at −80°C until use. Aortic samples were acquired from nine patients with AD Stanford type A who underwent surgical aortic repair (Table   S1 ). Patients with Marfan syndrome, Ehlers-Danlos syndrome, Loeys-Dietz syndrome, Turner syndrome, congenital bi-leaflet aortic valves, aortic aneurysm, traumatic dissection, and other connective tissue disorders, or those aged <18 years were excluded. Control aortic samples were collected from eight donors who died from nonvascular diseases (Table S1 ). The aortic sample was rapidly collected within 30 minutes after excision. All specimens were rinsed at least five times in precooled saline; then, the thrombus and adventitia were removed immediately using eye scissors and sterile tweezers on a clean Petri dish, and then, tissue samples were sliced into approximately 2mm sections and placed in sterile Eppendorf (EP) tubes, followed by stored at liquid nitrogen for use. The entire procedure was performed within 10 minutes. No additional operation was performed beyond the standard procedure to obtain above samples. The demographic and clinical characteristics of participants are presented in Table 1 .
The present study has been approved by the Medical Ethics Committee of Guangdong General Hospital and conducted complying with the Declaration of Helsinki. Written informed consents were obtained from each participant before inclusion.
| RNA isolation and quantitative reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA containing small RNAs was extracted from aorta tissue or cultured VSMCs using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA), then reversely transcribed into complementary DNA (cDNA) using a Geneseed II First Strand cDNA Synthesis Kit (Geneseed Biotech Co., Ltd. Guangdong, China) according to the manufacturer's protocols. 9 A PrimeScript Reverse Transcription (RT) Reagent Kit (TaKaRa, Tokyo, Japan) was used to synthesize cDNA with 500 ng of total RNA. Subsequently, quantitative PCR was performed using the Geneseed Quantitative Polymerase Chain Reaction (qPCR) SYBR Green Master Mix (Geneseed Biotech Co., Ltd.) in ABI 7500 machine (ABI, Waltham, MA, USA) according to the manufacturer's protocol. According to gene sequences published in GenBank, primers shown in Table 2 were constructed using Primer 5.0 software (Molecular Biology Insights, Colorado Springs, CO, USA) and checked by Oligo 7 and NCBI BLAST.
Negative controls (without template) were included in each step. Each SYBR Green reaction mixture (total volume, 20 µL) contained 2 µL of cDNA as template and 10 µmol/L of each primer. The RT reaction was conducted at 25°C for 10 minutes, subsequently 42°C for 15 minutes and 85°C for 5 minutes. PCR mixture was incubated at 95°C for 5 minutes, then 40 cycles at 95°C for 10 seconds, 60°C for 34 seconds, and 60°C for 60 seconds, respectively. After the final cycle of qRT-PCR, the samples were taken to the heat dissociation protocol to check for the presence of the only peak to identify the only one qRT-PCR product detected by SYBR Green dye. With β-actin as internal control, the reliability of qRT-PCR was assessed using the melting curve. The ∆Cq was obtained, and the relative miR expression level was determined using 
| Western immunoblotting
| Luciferase assay
The 3′-untranslated region (UTR) sequence of SMAD4 gene containing miR146a-5p-binding sites was amplified using PCR. The 3′-UTR sequence was cloned into the pMIR-REPORT luciferase vector 
| Cell culture and transfection
| Transwell HASMC migration assays
Human arterial smooth muscle cells were seeded into a 24-well plate with density of 2 × 10 4 /well, incubated overnight, and then trans- 
| Cell proliferation assay
Cell proliferation was examined using cell counting kit-8 (Dojindo, Japan) according to the manufacturer's protocols. VSMCs were seeded in 96-well plates with density of 5 × 10 3 cells per well. After adhesion, VSMCs were incubated in 1% fetal bovine serum (FBS)
M199 media for 24 hours, followed by treatment with adenovirus at multiple infection of MOI 120 with 15% FBS M199, and the medium was displaced every 24 hours. Subsequently, 10 mL of cell counting kit-8 reagent was titrated to each well 0, 12, 24, 36, and 48 hours after transfection, and the cells were further incubated for 4 hours at 37°C. The absorbance at 450 nm was read using a spectrophotometric plate reader. VSMCs that taken as negative controls were transfected with adenovirus without the miR146a-5p interfering effect.
| HASMC viability 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide assay
Human arterial smooth muscle cells were seeded in 96-well plates at a density of 5 × 10 4 cells/well, grown overnight, and then transfected with miR146a-5p mimics or inhibitors using Lipofectamine After mixing well, the absorbance at 490 nm was determined using a microplate reader (Bio-Rad 680, Hercules, CA, USA). The cell growth curve was plotted using the cell absorbance data. The experiment was performed in triplicate and repeated at least thrice.
| Apoptosis assay using flow cytometry
Human arterial smooth muscle cells were detached using 2.5% 
| Statistical analysis
All experimental data were expressed as mean ± standard devia- identify differences between groups. The Tukey's test was used for post hoc analyses. Significance was set at P < 0.05.
| RE SULTS
| Differential expression of miR146a-5p and SMAD4 in dissected vs normal aortic tissue specimens
The Western blot analysis was performed to detect the expression level of SMAD4 protein in the human aorta. As shown in Figure 1A 
| Overexpressed miR146a-5p increased HASMC proliferation and migration
Human arterial smooth muscle cells were transfected with miR146a-5p mimics or inhibitors to investigate whether miR146a-5p had a role in the regulation of biological functions of VSMCs ( Figure S1 ).
As determined by the cell viability MTT assay, the upregulation of miR146a-5p in HASMCs caused a evident increase in the number of proliferating cells, whereas the downregulation of miR146a-5p significantly decreased HASMC proliferation (Figure 2A) . The F I G U R E 1 Expression of SMAD4 and miR146a-5p in human aorta samples with NA and AD, respectively. A and B, Western blot analysis for SMAD4 protein expression in human aorta samples (n = 5 per group). SMAD4 protein expression was significantly downregulated in AD samples (P < 0.01). C, qPCR for SMAD4 mRNA expression in human aorta samples (n = 9 for the AD group and 8 for the NA group). SMAD4 mRNA expression was significantly downregulated in AD samples (P < 0.01). D, qPCR for miR146a-5p expression in human aorta samples (n = 9 for the AD group and 8 for the NA group). The expression of miR146a-5p was significantly upregulated in AD samples (P < 0.05).
Transwell test was performed to identify the role of miR146a-5p in HASMC migration. Treatment with miR146a-5p mimics substantially promoted the migration response in cultured HASMCs. In contrast, the downregulation of miR146a-5p had no effect on migration ( Figure 2B,D) . Furthermore, a flow cytometry test was performed to evaluate the effect of miR146a-5p on HASMC apoptosis. No significant change in the apoptosis of HASMCs was observed after transfection with miR146a-5p mimics (Figure 2C,E) . These in vitro observations revealed that miR146a-5p participated in HASMC proliferation and migration.
| Expression of SMAD4 was regulated by miR146a-5p
TargetScan and miRanda were used to analyze the predicted targets of miR146a-5p so as to explore the underlying effects of miR146a-5p on HASMC migration and proliferation. The study found that one target gene for miR146a-5p was SMAD4. One putative binding site was found at 390-397, which was highly conserved across species, as shown in Figure 3A , and therefore, the wild-type or mutant 3'-UTR of SMAD4 was cloned into a luciferase vector.
The luciferase reporter assay was used to confirm the predictions. The wild-type (WT) 3′-UTR and the mutated-type (Mut) 3′UTR of SMAD4 luciferase reporter vectors were constructed. 293T cells were co-transfected with miR146a-5p mimics and WT or Mut luciferase reporter vector. The relative luciferase activity significantly reduced in 293T cells co-transfected with miR146a-5p mimics and WT luciferase vector ( Figure 3B ). The activity of Mut luciferase reporter activity was not affected by miR146a-5p mimics in 293T cells.
Therefore, miR146a-5p directly bound to 3′-UTR of SMAD4.
miR146a-5p mimics and inhibitors were transfected into
HASMCs to further confirm whether SMAD4 was directly regulated by miR146a-5p. The expression of SMAD4 mRNA and protein was detected using qPCR ( Figure 4A ) and Western blot analysis ( Figure 4B,C) , respectively. The results demonstrated that the expression of SMAD4 was reduced with miR146a-5p overexpression in HASMCs, whereas miR146a-5p inhibitor increased SMAD4 mRNA and protein expression in HASMCs.
F I G U R E 2 In vitro transfection of miR146a-5p mimics or inhibitors strongly altered HASMC proliferation and migration. A, Proliferation curves of HASMCs transfected with control, miR-146a-5p mimics, mimics control, inhibitors, and inhibitors control. The result showed that the proliferation ability of HASMCs was significantly inhibited 72 h after the treatment with miR-146a-5p inhibitors. On the contrary, miR146a-5p mimics improved the proliferation ability of HASMCs compared with miR-146a-5p inhibitors control (n = 5 per group). B, Results of the Transwell test showed decreased migration ability in the miR-146a-5p inhibitor group, but it significantly improved in the miR-146a-5p mimics group. Quantified data were presented as the number of migrating cells per high-power field (n = 5 per group). C, The flow cytometric analysis showed that the transfection of miR146a-5p mimics or inhibitors had no effect on HASMC apoptosis (n = 5 per group). D and E, Data were represented as mean ± SD. All the experiments were performed thrice
| Circulating miR-146a-5p level was elevated in the AD group
Forty AD patients and 36 healthy controls included for circulating miR-146a level determination showed no significant difference in age, gender, incidence of coronary artery diseases, incidence of diabetes, family history, and liver and renal functions between two groups (P > 0.05) (Table S2) , whereas incidence of hypertension and smoking rate were significantly higher in the AD group (93.02% vs 13.89 P < 0.05, and 34.88% vs 8.33% P < 0.05, respectively). As expected, the level of circulating miRNA-146a-5p was significantly higher in AD patients as compared with that in normal controls ( Figure 5 ).
| D ISCUSS I ON
The involvement of miRNAs in aortic diseases has been reported in recent years. [10] [11] [12] [13] A previous study profiled dysregulated miRNA expression in AD and found the expression of miR146a-5p to be upregulated. 14 Dysfunction of the miR-146 family has often been linked to inflammation and malignancies. 7 However, no published study exists about the role of miR146a-5p in the pathogenesis. The present study was performed to confirm the expression pattern of miR146a-5p in AD and its regulatory role in the biological functions of VSMC's.
The study showed that miR146a-5p was significantly upregulated in AD tissues. Subsequently, the role of miR146a-5p in VSMC proliferation, migration, and apoptosis was explored. The result showed that miR146a-5p overexpression increased VSMC proliferation and migration, whereas the deletion of miR146a-5p with a specific inhibitor decreased VSMC migration and proliferation. Finally, the level of circulating miRNA-146a-5p was significantly higher in AD patients as compared with healthy controls, further corroborating the association of miR146a-5p with AD and implying miR146a-5p as a potential candidate for biomarker of AD.
Previous investigations have revealed a critical role of VSMCs in aortic walldegeneration, which has been identified as the initiation of pathologic remodeling in AD. 9, 15, 16 Remarkably, abnormal proliferation and migration of VSMCs have been considered potentially as the main cause of pathological vascular remodeling and vascular disease through undermining the vasculature stability. 17 Of note, Müller et al and Wang et al observed that VSMCs from dissected aorta proliferated more rapidly than VSMCs from normal aorta tissues, and the genes participate in proliferation exhibited an increased expression. 18, 19 Similar to in vitro data, VSMCs overexpressing miR146a-5p
showed enhanced proliferation and migration, indicating a potential involvement for miR146a-5p in the AD pathogenesis. Therefore, prospective AD cohort study, as well as further in vitro studies with VSMCs lines from dissected aorta, should be performed to address these shortcomings in the future.
In summary, this study suggested upregulation of miR146a-5p and downregulation of SMAD4 in AD tissues. The ectopic expression of miR146a-5p could promote VSMC proliferation and migration, whereas miR146a-5p negatively regulated the expression of SMAD4 by targeting the 3'-UTR of SMAD4. Therefore, the results suggested that miR146a-5p participated in the pathogenesis of AD by directly targeting SMAD4, providing new insights into effective prevention and treatment of AD.
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